399 related articles for article (PubMed ID: 16314648)
1. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
[TBL] [Abstract][Full Text] [Related]
2. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial.
Ferreira MR; Dolan NC; Fitzgibbon ML; Davis TC; Gorby N; Ladewski L; Liu D; Rademaker AW; Medio F; Schmitt BP; Bennett CL
J Clin Oncol; 2005 Mar; 23(7):1548-54. PubMed ID: 15735130
[TBL] [Abstract][Full Text] [Related]
3. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
Shankaran V; McKoy JM; Dandade N; Nonzee N; Tigue CA; Bennett CL; Denberg TD
J Clin Oncol; 2007 Nov; 25(33):5248-53. PubMed ID: 18024871
[TBL] [Abstract][Full Text] [Related]
4. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center.
Fitzgibbon ML; Ferreira MR; Dolan NC; Davis TC; Rademaker AW; Wolf MS; Liu D; Gorby N; Schmitt BP; Bennett CL
Health Promot Pract; 2007 Jul; 8(3):273-81. PubMed ID: 17606952
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
Lairson DR; DiCarlo M; Myers RE; Wolf T; Cocroft J; Sifri R; Rosenthal M; Vernon SW; Wender R
Cancer; 2008 Feb; 112(4):779-88. PubMed ID: 18098272
[TBL] [Abstract][Full Text] [Related]
6. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
7. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening.
Ling BS; Schoen RE; Trauth JM; Wahed AS; Eury T; Simak DM; Solano FX; Weissfeld JL
Arch Intern Med; 2009 Jan; 169(1):47-55. PubMed ID: 19139323
[TBL] [Abstract][Full Text] [Related]
8. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
9. Costs and cost-effectiveness of colorectal cancer prevention and therapy.
Schrag D; Weeks J
Semin Oncol; 1999 Oct; 26(5):561-8. PubMed ID: 10528905
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of an intervention to increase cancer screening in primary care settings.
Chirikos TN; Christman LK; Hunter S; Roetzheim RG
Prev Med; 2004 Aug; 39(2):230-8. PubMed ID: 15226030
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
12. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
[TBL] [Abstract][Full Text] [Related]
13. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
Berchi C; Bouvier V; Réaud JM; Launoy G
Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
[TBL] [Abstract][Full Text] [Related]
15. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening.
Costanza ME; Luckmann R; Stoddard AM; White MJ; Stark JR; Avrunin JS; Rosal MC; Clemow L
Cancer Detect Prev; 2007; 31(3):191-8. PubMed ID: 17646058
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of work-site cholesterol screening and intervention programs.
Wilson MG; Edmunson J; DeJoy DM
J Occup Med; 1992 Jun; 34(6):642-9. PubMed ID: 1619496
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
Fisher DA; Galanko J; Dudley TK; Shaheen NJ
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
